关注
Tim Liebner
Tim Liebner
Postdoctoral Researcher, Novo Nordisk Center for Protein Research University of Copenhagen
在 cpr.ku.dk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release
T Narita, S Ito, Y Higashijima, WK Chu, K Neumann, J Walter, S Satpathy, ...
Molecular Cell 81 (10), 2166-2182. e6, 2021
1522021
Acetylation of histone H2B marks active enhancers and predicts CBP/p300 target genes
T Narita, Y Higashijima, S Kilic, T Liebner, J Walter, C Choudhary
Nature Genetics 55 (4), 679-692, 2023
342023
HDAC6 modulates myofibril stiffness and diastolic function of the heart
YH Lin, JL Major, T Liebner, Z Hourani, JG Travers, SA Wennersten, ...
The Journal of Clinical Investigation 132 (10), 2022
312022
A unique H2B acetylation signature marks active enhancers and predicts their target genes
T Narita, Y Higashijima, S Kilic, T Liebner, J Walter, C Choudhary
bioRxiv, 2022.07. 18.500459, 2022
72022
Acetylation of histones and non-histone proteins is not a mere consequence of ongoing transcription
T Liebner, S Kilic, J Walter, H Aibara, T Narita, C Choudhary
Nature Communications 15 (1), 4962, 2024
42024
Histone deacetylase inhibitors butyrate and bufexamac inhibit de novo HIV-1 infection in CD4 T-cells
L Chen, A Zutz, J Phillippou-Massier, T Liebner, OT Keppler, ...
bioRxiv, 2020.04. 29.067884, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–6